Preclinical data presented at the Society for Immunotherapy of Cancer Annual Meeting show the potential of cancer-targeted myeloid cells, reprogrammed in the body through the use of chimeric antigen receptor-encoding mRNA encapsulated in lipid nanoparticles, to shrink metastases and suppress tumor growth.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2159-8290.CD-NB2023-0083 | DOI Listing |
Publication Analysis
Top Keywords
vivo car
4
car monocytes
4
monocytes efficacy
4
efficacy mice
4
mice preclinical
4
preclinical data
4
data presented
4
presented society
4
society immunotherapy
4
immunotherapy cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!